Clinical Trial: Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group (CWS) for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children, Adolesce

Brief Summary: The purpose of this study is to investigate whether the addition of oral maintenance chemotherapy with O-TIE (Etoposide, Idarubicin, Trofosfamide) for 6 months improves the event free survival (EFS) in patients with localised high-risk RMS and RMS-like Soft Tissue Sarcoma.

Detailed Summary:
Sponsor: University Hospital Tuebingen

Current Primary Outcome: event free survival (EFS) [ Time Frame: 3 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Overall survival [ Time Frame: 5 years ]

Original Secondary Outcome: Same as current

Information By: University Hospital Tuebingen

Dates:
Date Received: April 2, 2009
Date Started: July 2009
Date Completion: July 2024
Last Updated: May 13, 2016
Last Verified: May 2016